| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Yeny Acosta-Ampudia, Diana M Monsalve, Carolina Ramírez-Santan. Identifying the culprits in neurological autoimmune diseases. Journal of translational autoimmunity. vol 2. 2020-09-28. PMID:32743503. |
multiple sclerosis (ms) is the most common nad, whereas guillain-barré syndrome (gbs), myasthenia gravis (mg), and neuromyelitis optica (nmo) are less common nads, but the incidence of these diseases has increased exponentially in the last few years. |
2020-09-28 |
2023-08-13 |
Not clear |
| S Jarius, B Wildeman. Devic's index case: A critical reappraisal - AQP4-IgG-mediated neuromyelitis optica spectrum disorder, or rather MOG encephalomyelitis? Journal of the neurological sciences. vol 407. 2020-09-16. PMID:31726278. |
subsequently, devic became the eponym of neuromyelitis optica (nmo), which was then referred to as "devic's syndrome", "devic's disease" or "morbus devic". |
2020-09-16 |
2023-08-13 |
Not clear |
| Fumitaka Shimizu, Yukio Takeshita, Yuka Hamamoto, Hideaki Nishihara, Yasuteru Sano, Masaya Honda, Ryota Sato, Toshihiko Maeda, Toshiyuki Takahashi, Susumu Fujikawa, Takashi Kand. GRP 78 antibodies are associated with clinical phenotype in neuromyelitis optica. Annals of clinical and translational neurology. vol 6. issue 10. 2020-09-07. PMID:31568704. |
we previously reported the association between blood-brain barrier (bbb) dysfunction and glucose-regulated protein 78 (grp 78) autoantibodies in neuromyelitis optica (nmo). |
2020-09-07 |
2023-08-13 |
Not clear |
| Sarah M Carpanini, Megan Torvell, Bryan Paul Morga. Therapeutic Inhibition of the Complement System in Diseases of the Central Nervous System. Frontiers in immunology. vol 10. 2020-09-02. PMID:30886620. |
genetic and epidemiological studies, cerebrospinal fluid (csf) and plasma biomarker measurements and pathological analysis of post-mortem tissues have all implicated complement in multiple cns diseases including multiple sclerosis (ms), neuromyelitis optica (nmo), neurotrauma, stroke, amyotrophic lateral sclerosis (als), alzheimer's disease (ad), parkinson's disease (pd), and huntington's disease (hd). |
2020-09-02 |
2023-08-13 |
human |
| Sashank Prasad, John Che. What You Need to Know About AQP4, MOG, and NMOSD. Seminars in neurology. vol 39. issue 6. 2020-08-24. PMID:31847043. |
neuromyelitis optica (nmo) is an antibody-mediated inflammatory disease of the central nervous system with a predilection for the optic nerves, spinal cord, and certain brain regions. |
2020-08-24 |
2023-08-13 |
Not clear |
| Manabu Arak. Blockade of IL-6 signaling in neuromyelitis optica. Neurochemistry international. vol 130. 2020-08-18. PMID:30342072. |
neuromyelitis optica (nmo) and neuromyelitis optica spectrum disorder (nmosd) are autoimmune diseases associated with a disease-specific autoantibody directed against the water channel protein aquaporin-4. |
2020-08-18 |
2023-08-13 |
Not clear |
| Silvia Ciappelloni, Delphine Bouchet, Nadège Dubourdieu, Eric Boué-Grabot, Blanka Kellermayer, Constance Manso, Romain Marignier, Stéphane H R Oliet, Thomas Tourdias, Laurent Gro. Aquaporin-4 Surface Trafficking Regulates Astrocytic Process Motility and Synaptic Activity in Health and Autoimmune Disease. Cell reports. vol 27. issue 13. 2020-07-30. PMID:31242419. |
furthermore, human autoantibodies directed against aqp4 from neuromyelitis optica (nmo) patients impaired aqp4-m23 dynamic distribution and, consequently, astrocyte process and synaptic activity. |
2020-07-30 |
2023-08-13 |
human |
| S Jarius, B Wildeman. The history of neuromyelitis optica. Part 2: 'Spinal amaurosis', or how it all began. Journal of neuroinflammation. vol 16. issue 1. 2020-07-14. PMID:31883522. |
neuromyelitis optica (nmo) was long considered a clinical variant of multiple sclerosis (ms). |
2020-07-14 |
2023-08-13 |
Not clear |
| Antonia Ceccarelli, Victoria Ann Mifsud, Amna Dogar, Syed Irteza Hussai. Seropositive neuromyelitis optica spectrum disorder in Emirati patients: A case series. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. vol 72. 2020-07-13. PMID:31859181. |
to describe clinical and radiological characteristics of seropositive neuromyelitis optica (nmo) in emirati patients. |
2020-07-13 |
2023-08-13 |
Not clear |
| Livnat Brill, Adi Vaknin-Dembinsky, Omri Zveik, Nitsan Haham, Keren Miller, Gil Benede. MIF -173G/C polymorphism is associated with NMO disease severity. Journal of neuroimmunology. vol 339. 2020-07-09. PMID:31790982. |
our knowledge about genetic factors that drive the worsening of neuromyelitis optica (nmo) is limited. |
2020-07-09 |
2023-08-13 |
Not clear |
| Ryuji Sakakibar. Neurogenic lower urinary tract dysfunction in multiple sclerosis, neuromyelitis optica, and related disorders. Clinical autonomic research : official journal of the Clinical Autonomic Research Society. vol 29. issue 3. 2020-07-03. PMID:30076494. |
multiple sclerosis (ms), neuromyelitis optica (nmo), and related disorders are major immune-mediated central nervous system diseases affecting the spinal cord. |
2020-07-03 |
2023-08-13 |
Not clear |
| Forough Foolad, Fariba Khodagholi, Seyed Massood Nabavi, Mohammad Java. Changes in mitochondrial function in patients with neuromyelitis optica; correlations with motor and cognitive disabilities. PloS one. vol 15. issue 3. 2020-06-29. PMID:32214385. |
neuromyelitis optica (nmo) is an inflammatory demyelinating disease that mainly affects optic nerves and spinal cord. |
2020-06-29 |
2023-08-13 |
Not clear |
| Yan Wu, Lianmei Zhong, Jia Gen. Visual impairment in neuromyelitis optica spectrum disorders (NMOSD). Journal of chemical neuroanatomy. vol 97. 2020-06-26. PMID:30716473. |
neuromyelitis optica (nmo) and nmo spectrum disorders (nmosd) have garnered attention due to their high pathogenicity, high risk of relapse, and poor prognosis as an inflammatory central nervous system (cns) syndrome. |
2020-06-26 |
2023-08-13 |
Not clear |
| Soichi Enomoto, Hiroko Shigemi, Yuki Kitazaki, Masamichi Ikawa, Osamu Yamamura, Tadanori Hamano, Katsunori Tai, Hiromichi Iwasaki, Haruka Koizumi, Minoru Hasegawa, Kiminobu Takeda, Yasunari Nakamot. Cladophialophora bantiana infection mimicking neuromyelitis optica. Journal of the neurological sciences. vol 399. 2020-06-18. PMID:30822604. |
we report a japanese case of c. bantiana presenting with myelitis mimicking neuromyelitis optica (nmo) and brain abscess. |
2020-06-18 |
2023-08-13 |
Not clear |
| Xi Guo, Jiajia Zhu, Ningnannan Zhang, Linjie Zhang, Yuan Qi, Huanhuan Cai, Xue Zhang, Jie Sun, Qiuhui Wang, Li Yang, Fu-Dong Shi, Chunshui Y. Altered neurovascular coupling in neuromyelitis optica. Human brain mapping. vol 40. issue 3. 2020-05-27. PMID:30315685. |
neuromyelitis optica (nmo) is an autoimmune inflammatory demyelinating disease of the central nervous system and shows cognitive decline-related brain gray matter abnormalities besides the damage of optic nerve and spinal cord. |
2020-05-27 |
2023-08-13 |
Not clear |
| Axel Petzold, Mark Woodhall, Z Khaleeli, W Oliver Tobin, Sean J Pittock, B G Weinshenker, Angela Vincent, Patrick Waters, Gordon T Plan. Aquaporin-4 and myelin oligodendrocyte glycoprotein antibodies in immune-mediated optic neuritis at long-term follow-up. Journal of neurology, neurosurgery, and psychiatry. vol 90. issue 9. 2020-05-06. PMID:31118222. |
to re-evaluate serum samples from our 2007 cohort of patients with single-episode isolated on (sion), recurrent isolated on (rion), chronic relapsing inflammatory optic neuropathy (crion), multiple sclerosis-associated on (mson) and neuromyelitis optica (nmo). |
2020-05-06 |
2023-08-13 |
Not clear |
| John Soltys, Yiting Liu, Alanna Ritchie, Scott Wemlinger, Kristin Schaller, Hannah Schumann, Gregory P Owens, Jeffrey L Bennet. Membrane assembly of aquaporin-4 autoantibodies regulates classical complement activation in neuromyelitis optica. The Journal of clinical investigation. vol 129. issue 5. 2020-04-21. PMID:30958797. |
neuromyelitis optica (nmo) is an autoimmune cns disorder mediated by pathogenic aquaporin-4 (aqp4) water channel autoantibodies (aqp4-igg). |
2020-04-21 |
2023-08-13 |
human |
| J N Williams, C B Speyer, D J Kreps, D J Kimbrough, K Costenbader, S Bhattacharyy. Spinal cord syndromes in patients with systemic lupus erythematosus: differentiating lupus myelitis, neuromyelitis optica, and multiple sclerosis. Lupus. vol 28. issue 14. 2020-04-16. PMID:31679449. |
non-infectious myelitis in systemic lupus erythematosus (sle) may be due to sle myelitis, comorbid multiple sclerosis (ms), or neuromyelitis optica (nmo). |
2020-04-16 |
2023-08-13 |
Not clear |
| Pablo García-Miranda, Francisco J Morón-Civanto, Maria Del Mar Martínez-Olivo, Nela Suárez-Luna, Reposo Ramírez-Lorca, Lucía Lebrato-Hernández, Raquel Lamas-Pérez, Guillermo Navarro, Javier Abril-Jaramillo, Maria Isabel García-Sánchez, José Luis Casado-Chocán, Antonio José Uclés-Sánchez, Mercedes Romera, Miriam Echevarría, María Díaz-Sánche. Predictive Value of Serum Antibodies and Point Mutations of AQP4, AQP1 and MOG in A Cohort of Spanish Patients with Neuromyelitis Optica Spectrum Disorders. International journal of molecular sciences. vol 20. issue 22. 2020-04-07. PMID:31752329. |
the detection of igg aquaporin-4 antibodies in the serum of patients with neuromyelitis optica (nmo) has dramatically improved the diagnosis of this disease and its distinction from multiple sclerosis. |
2020-04-07 |
2023-08-13 |
Not clear |
| Krishna K Machavaram, Chihiro Endo-Tsukude, Kimio Terao, Katherine L Gill, Oliver J Hatley, Iain Gardner, Neil Parrott, Patricia Sanwald Ducra. Simulating the Impact of Elevated Levels of Interleukin-6 on the Pharmacokinetics of Various CYP450 Substrates in Patients with Neuromyelitis Optica or Neuromyelitis Optica Spectrum Disorders in Different Ethnic Populations. The AAPS journal. vol 21. issue 3. 2020-03-02. PMID:30887238. |
the pbpk model was then used to simulate the change in oral exposure of the probe substrates in north european caucasian, chinese, and japanese population of patients with neuromyelitis optica (nmo) or nmo spectrum disorder with elevated plasma il-6 levels (up to 100 pg/ml). |
2020-03-02 |
2023-08-13 |
human |